89 related articles for article (PubMed ID: 28325510)
1. Increased nuclear localization of substance P in human gastric tumor cells.
Muñoz M; Rosso M; Carranza A; Coveñas R
Acta Histochem; 2017 Apr; 119(3):337-342. PubMed ID: 28325510
[TBL] [Abstract][Full Text] [Related]
2. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
Rosso M; Robles-Frías MJ; Coveñas R; Salinas-Martín MV; Muñoz M
Tumour Biol; 2008; 29(4):245-54. PubMed ID: 18781096
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of NK-1 receptor and Substance P in human normal placenta.
Muñoz M; Pavón A; Rosso M; Salinas MV; Pérez A; Carranza A; González-Ortega A
Placenta; 2010 Jul; 31(7):649-51. PubMed ID: 20430440
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of substance P and NK-1 receptor in Hofbauer cells in human normal placenta.
Muñoz M; Carranza A; Pavón A; Anderson G; Coveñas R
Microsc Res Tech; 2013 Dec; 76(12):1310-3. PubMed ID: 24155270
[TBL] [Abstract][Full Text] [Related]
5. Involvement of substance P and the NK-1 receptor in cancer progression.
Muñoz M; Coveñas R
Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
[TBL] [Abstract][Full Text] [Related]
6. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
Muñoz M; Coveñas R
World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
[TBL] [Abstract][Full Text] [Related]
7. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
[TBL] [Abstract][Full Text] [Related]
8. The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study.
Isorna I; Esteban F; Solanellas J; Coveñas R; Muñoz M
Eur J Histochem; 2020 Apr; 64(2):. PubMed ID: 32363847
[TBL] [Abstract][Full Text] [Related]
9. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
10. Cancer progression and substance P.
Coveñas R; Muñoz M
Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
[TBL] [Abstract][Full Text] [Related]
11. Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells.
Feng F; Yang J; Tong L; Yuan S; Tian Y; Hong L; Wang W; Zhang H
Cell Biol Int; 2011 Jun; 35(6):623-9. PubMed ID: 21091434
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
Muñoz M; Coveñas R
Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
[TBL] [Abstract][Full Text] [Related]
13. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R
Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857
[TBL] [Abstract][Full Text] [Related]
14. The antiproliferative action of [D-Arg(1), D-Phe(5), D-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist.
Munoz M; Recio S; Rosso M; Redondo M; Covenas R
J Physiol Pharmacol; 2015 Jun; 66(3):421-6. PubMed ID: 26084224
[TBL] [Abstract][Full Text] [Related]
15. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of substance P and NK-1 receptor in vascular anomalies.
Ortiz-Prieto A; Bernabeu-Wittel J; Zulueta-Dorado T; Lorente-Lavirgen AI; Muñoz M
Arch Dermatol Res; 2017 Mar; 309(2):97-102. PubMed ID: 27988892
[TBL] [Abstract][Full Text] [Related]
18. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus.
González Moles MA; Esteban F; Ruiz-Avila I; Gil Montoya JA; Brener S; Bascones-Martínez A; Muñoz M
Oral Dis; 2009 Mar; 15(2):162-9. PubMed ID: 19036058
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
Jang TJ; Kim UJ
Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
[TBL] [Abstract][Full Text] [Related]
20. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon.
Andersson G; Danielson P; Alfredson H; Forsgren S
Regul Pept; 2008 Oct; 150(1-3):81-7. PubMed ID: 18394729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]